Epithelial Ovarian Cancer
Links shared publicly online about this topic
Predicting Cellular Response To Paclitaxel In Epithelial Ovarian Cancer
medicalnewstoday.com — “New research findings by UCD scientists published online today in the Journal of Pathology may help clinicians predict how patients with high grade, serous, epithelial ovarian cancer will respond” View full resource at medicalnewstoday.com
Most Recently Shared on November 12, 2011 at 8:05 am By:
MNT Ovarian Cancer Health News
Predicting Cellular Response To Paclitaxel In Epithelial Ovarian Cancer http://t.co/X7z0k7d9 #ovariancancer
Cancer Stem Cells and Epithelial Ovarian Cancer
hindawi.com — “The cancer stem cell hypothesis is becoming more widely accepted as a model for carcinogenesis. Tumours are heterogeneous both at the molecular and cellular level, containing a small population of cells that possess highly tumourigenic --stem-cell-- properties. Cancer stem cells (CSCs), or tumour-initiating cells, have the ability to self-renew, generate xenografts reminiscent of the primary tumour that they were derived from, and are chemoresistant. The characterisation of the CSC population wi” View full resource at hindawi.com
Most Recently Shared on January 25, 2011 at 3:47 pm By:
Cancer Stem Cells and Epithelial Ovarian Cancer: The cancer stem cell hypothesis is becoming more widely accepte... http://bit.ly/hshKJD
Risk Factors for Epithelial Ovarian Cancer by Histologic Subtype
aje.oxfordjournals.org — “Risk Factors for Epithelial Ovarian Cancer by Histologic Subtype” View full resource at aje.oxfordjournals.org
Most Recently Shared on December 23, 2009 at 11:48 am By:
Mark Robson Physician, Doctor, Internist, Oncologist, and Hematologist
Risk Factors for Epithelial Ovarian Cancer by Histologic Subtype http://bit.ly/7jdnPx
Predicting cellular response to paclitaxel in epithelial ovarian cancer
medicalxpress.com — “(Medical Xpress) -- New research findings by UCD scientists published online in the Journal of Pathology may help clinicians predict how patients with high grade, serous, epithelial ovarian cancer will respond to paclitaxel chemotherapy (Taxol).” View full resource at medicalxpress.com
Most Recently Shared on November 16, 2011 at 4:09 pm By:
Predicting cellular response to paclitaxel in epithelial ovarian cancer: (Medical Xpress) -- New research findin... http://t.co/Wd8cS7gk
Epithelial Ovarian Cancer and the Occurrence of Skin Cancer in The Netherlands: Histological Type Connotations
hindawi.com — “Background. Patients with epithelial ovarian cancer have a high risk of (non-)melanoma skin cancer. The association between histological variants of primary ovarian cancer and skin cancer is poorly documented. Objectives. To further evaluate the risk of skin cancer based on the histology of the epithelial ovarian cancer. Methods. A cross-sectional study within a large population-based dataset. Results. Skin cancer was found in ( CI: 2.3--3.1) of the 5366 individuals forming our dataset. The odds” View full resource at hindawi.com
Most Recently Shared on April 12, 2011 at 5:06 am By:
Epithelial Ovarian Cancer and the Occurrence of Skin Cancer in The Netherlands: Histological Type Connotations: ... http://bit.ly/gB8GEt
Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
hindawi.com — “The prognosis of epithelial ovarian cancer (EOC), the primary cause of death from gynaecological malignancies, has only modestly improved over the last decades. Immunotherapeutic treatment using a cocktail of antigens has been proposed as a universal vaccine strategy. We determined the expression of tumor antigens in the context of MHC class I expression in 270 primary tumor samples using tissue microarray. Expression of tumor antigens p53, SP17, survivin, WT1, and NY-ESO-1 was observed in 120 (” View full resource at hindawi.com
Most Recently Shared on September 16, 2010 at 5:36 pm By:
Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer: The prognosis of epithelial ovaria... http://bit.ly/9bvqcI
Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?
hindawi.com — “Epithelial ovarian cancer (EOC) continues to represent one of the most lethal conditions in women in the western countries. With the shifting of childbearing towards higher age, EOC increasingly affects women with active childbearing wish, resulting in major impacts on treatment management. Next to the optimal therapeutic treatment strategies, gynecologic oncologists are being asked to incorporate into their decision-making processes the patients' wish for fertility preserving alternatives ideal” View full resource at hindawi.com
Most Recently Shared on February 24, 2012 at 4:55 am By:
Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?: Epithelial ovarian cancer (EOC) ... http://t.co/Xs7anIgA
Novel set of genes linked with epithelial ovarian cancer patient survival
news-medical.net — “Researchers at Moffitt Cancer Center and colleagues from 11 other institutions in the United States and the United Kingdom have used two genome-wide association studies (GWAS) - one from the U.S. and one from the U.K. - to detect a novel set of genes found to be associated with epithelial ovarian cancer patient survival.” View full resource at news-medical.net
Most Recently Shared on March 7, 2012 at 9:49 am By:
Ovarian Cancer News: Novel set of genes linked with epithelial ovarian cancer patient survival: Researchers at M... http://t.co/KZKDWahE
VCA Clinical Fellowship awarded for epithelial ovarian cancer research
news-medical.net — “Dr Clare Scott from the Walter and Eliza Hall Institute in Melbourne, Australia, has been awarded a Victorian Cancer Agency (VCA) Clinical Fellowship to further research into an aggressive and highly lethal form of ovarian cancer.” View full resource at news-medical.net
Most Recently Shared on October 27, 2010 at 9:52 am By:
Ovarian Cancer News: VCA Clinical Fellowship awarded for epithelial ovarian cancer research: Dr Clare Scott from t... http://bit.ly/cU9Xh8
VCA Clinical Fellowship awarded for epithelial ovarian cancer research
news-medical.net — “Dr Clare Scott from the Walter and Eliza Hall Institute in Melbourne, Australia, has been awarded a Victorian Cancer Agency (VCA) Clinical Fellowship to further research into an aggressive and highly lethal form of ovarian cancer.” View full resource at news-medical.net
Most Recently Shared on October 27, 2010 at 10:43 am By:
VCA Clinical Fellowship awarded for epithelial ovarian cancer research: Dr Clare Scott from the Walter and Eliza H... http://bit.ly/de2Igg
Cancers From B to T: Most common Types of Cancer - Ovarian Cancer - Epithelial ovarian Cancer
thecancerhealingguide.blogspot.com — “Please note that all articles written by Kyle. J. Norton are for information and education only, please consult with your doctor or related field specialist before applying. http://medicaladvisorjournals.blogspot.com/” View full resource at thecancerhealingguide.blogspot.com
Most Recently Shared on November 11, 2011 at 2:57 pm By:
Ovarian Cancer - Epithelial ovarian Cancer http://t.co/QchMl8yS
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
hindawi.com — “Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer” View full resource at hindawi.com
Most Recently Shared on August 29, 2011 at 6:40 pm By:
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer: Thi... http://t.co/C0fygZk
Correlogic Systems' OvaCheck blood test for detection of epithelial ovarian cancer receives CE Mark
news-medical.net — “Correlogic Systems, Inc. announced today that OvaCheck, the company's blood test for the detection of epithelial ovarian cancer, has fulfilled European Union regulatory requirements (CE marking) for distribution and sale of the test. The path is now cleared for the test to be made available to patients in Europe through their physicians.” View full resource at news-medical.net
Most Recently Shared on June 9, 2010 at 6:27 pm By:
Ovarian Cancer News: Correlogic Systems' OvaCheck blood test for detection of epithelial ovarian cancer receives... http://buzzup.com/zv8r
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer " JCO
jco.ascopubs.org — “Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer " JCO” View full resource at jco.ascopubs.org
Most Recently Shared on September 17, 2010 at 11:38 am By:
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial O... http://bit.ly/b728h5
Abbott seeks U.S. approval for HE4 assay to monitor recurrence/progression of epithelial ovarian cancer
news-medical.net — “A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States. Abbott's ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or progression of epithelial ovarian cancer. If approved, this important immunoassay would be the first automated HE4 test available in the United States.” View full resource at news-medical.net
Most Recently Shared on February 9, 2010 at 9:15 am By:
Ovarian Cancer News: Abbott seeks U.S. approval for HE4 assay to monitor recurrence/progression of epithelial ovar... http://bit.ly/caAusz
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Ovarian Cancer
The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.
-
Ovarian Cancer OW
Organizing ovarian cancer resources shared by health experts, advocates, and organizations into WisdomCards.
-
Mark Robson
medical oncologist concentrating on clinical translation of germline genetics; opinions expressed here are my own, not my employer's
Advertisement
